Stop using now Drug recall · FDA · Published January 11, 2024

Par Sterile Products Vasostrict Injection Recall: Superpotent Drug Risk

Par Sterile Products recalls Vasostrict (vasopressin) injections due to potential overdose risk from assay exceeding stability limits. This affects specific lot numbers and expiration dates.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0232-2024Drug Par Sterile Products ›

Stop using this now

Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Take action

Contact the company

Recalling firmPar Sterile Products LLC870 Parkdale Rd · Rochester, MI 48307-1740

✎ GovInfoNow plain-language explainer

Par Sterile Products is recalling Vasostrict injections because the drug concentration may be too high, risking overdose. This is a serious issue for patients receiving intravenous treatments. Read more at govinfonow.com/recall/32884-par-sterile-products-vasostrict-injection-recall-superpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32884-par-sterile-products-vasostrict-injection-recall-superpotent-drug-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0232-2024

Cite this page

“Par Sterile Products Vasostrict Injection Recall: Superpotent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32884-par-sterile-products-vasostrict-injection-recall-superpotent-drug-risk. Based on FDA recall #D-0232-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0232-2024%22&limit=1).

Par Sterile Products LLC voluntarily recalled Vasostrict (vasopressin in 5% Dextrose) Injection nationwide due to assay levels exceeding upper specification limits, according to the FDA on Jan. 11, 2024.

How to tell if you have it

Brand: Par Sterile Products
Product: Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton
NDC: 42023-237-10
Lot #: 66702
Expiration: 02/2025

The hazard

The hazard is a superpotent drug risk because the assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Context

GovInfoNow's records show Par Sterile Products LLC has 3 other recalls on record since 2017-04-28. Other recent recalls of similar products include Somerset Therapeutics Cisatracurium Besylate Injection Recall (2025-11-26), Baxter Vasopressin Injection Recall (2026-08-06), and Reliance Pemetrexed Injection Recall (2026-06-24).

How to tell if you have this one

Check for vials labeled 'Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose'. The lot number is 66702 and expiration date is February 2025.

Brand
Par Sterile Products
Category
Drug

Based on the official FDA remedy

What to do — step by step

Stop Using Now
Immediately stop using the recalled Vasostrict injections if you have them.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 13 days after the firm started it.

Jan 11, 2024Firm started the recall
Jan 16, 2024FDA classified it Class II
Jan 24, 2024Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/32884-par-sterile-products-vasostrict-injection-recall-superpotent-drug-risk">Par Sterile Products Vasostrict Injection Recall: Superpotent Drug Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0232-2024 (January 11, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0232-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.